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ABSTRACT: 
 
The anti-inflammatory effect of the plant of Eclipta alba (Family – Asteraceae) was evaluated 
using carrageenin, mediators such as histamine and serotonin induced paw oedema, and cotton 
pellet induced granuloma tests for their effect on acute and chronic phase inflammation models 
in rats.  Maximum inhibition (55.85%) was noted at the dose of 500 mg/kg after 3 hr of drug 
treatment in carrageenin  induced paw oedema, whereas the Indomethacin (standard drug ) 
produced 61.30% of  inhibition.  In the chronic model (cotton pellet induced granuloma) the 
CEEA and standard drug showed decreased formation of granuloma tissue by 49.7,41.5,22.1% 
and 53.48 % respectively.  The results indicate the potent anti-inflammatory effect and 
therapeutic efficacy of Eclipta alba  extract on animal models, which is compared with 
Indomethacin. 
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INTRODUCTION 
 
Eclipta alba (Family – Asteraceae) grows in 
tropical and subtropical countries at an 
altitude upto 2000 meters.  It is commonly 
known as Karishalenganni  in Tamil.  The 
plant has a bitter, hot, sharp, dry taste and is 
used in Ayurveda for the treatment of 
‘Kapha’ and ‘Vata’.  The fresh plant is used 
in treating enlargement of the liver and 
spleen and in various chronic skin diseases.  
The plant is used in many Ayurvedic 
formulation for the relief of pain, as anti-
helmintic, antiflammation, in eye diseases, 
asthma and anaemia (1-4).  The fresh juice 
of the leaves is rubbed on the shaven scalp 
for the purpose of promoting the growth of 
hair.  The herb contains wedelolactone as 
coumestan derivatives, the first one has been 
responsible as a major anti-hepatotoxic 
compounds of this plant (5).  It is also 
reported triterpenoidal saponin (Eclalbatin) 
is present in this plant (6).  However, fewer 
reports are available with respect to the 
pharmacological properties of the plant.   
Keeping this in view, the present study has 
been undertaken to investigate the anti-
inflammatory studies of chloroform extract 
of Eclipta alba in standard animal models. 
 
Materials and Methods 
 
The plant species of Eclipta alba  were 
collected in Namakkal district of Tamilnadu, 
India.  Dr. S. Jayaram, (Director, Medicinal 
plant research unit and plant anatomy   Pages 112 - 118   
research center, Chennai, Tamilnadu, India) 
authenticated the plant and a specimen was 
preserved in the Department of 
pharmacognosy in our institutions for future 
references. 
 
Chemicals and Reagents 
 
The chemicals used in the present study 
were  carrageenin  (S.D. Fine Chemicals 
Limited, Bombay), histamine (Sigma, USA), 
5-hydroxy tryptamine hydrochloride 
(serotonin) (Sigma, USA), and 
Indomethacin (IPCA, Bombay). 
 
Preparation of Extract 
 
The dried powdered plant material was 
extracted with chloroform in a Soxhlet 
extraction apparatus.  The solvent was 
removed under reduced pressure  and semi 
solid mass was obtained (Yield 16.7%).  The 
extract showed positive test for alkaloids, 
steroids, and tannins.  The extract at the 
different doses of 50,100 and 200 Mg/kg 
was suspended in aqueous Tween 80 
solution (2%) and Indomethacin (10 mg/Kg) 
in saline were used for the present study. 
 
Phytochemical profile 
 
The phytochemcial profile was performed as 
described by Costa (19977).  It was 
determined by identification reactions based 
on the chemical group to be determined by 
thin layer chromatography. 
 
Animals 
 
Albino Wistar rats of the either sex (180-
120g) were used for the present study.  They 
were maintained under standard 
environmental conditions and were fed with 
standard pellet diet with water as libitum. 
 
Toxicity Study 
An acute toxicity study relating to the 
determination of LD50 was performed (7). 
 
Investigation of Anti-inflammatory 
effects: 
 
Carragenin Induced Paw odema (8) 
 
The rats were divided into 5 groups (n=6).  
The extract and the standard used for this 
study were prepared in the same manner as 
mentioned earlier.  Animals were deprived 
of food and water for 18 hours before the 
experiment.  On the day of the experiment 
they were assigned to 5 groups of six 
animals each.  They were marked and 
numbered for identification.  The test 
compounds and standard drugs were 
administered orally.  After 60 mins of 
administration of extracts and standard 
drugs 0.9% saline was injected to the lateral 
mallelolus on the sub plantar region of the 
right hind paw of the tats and paw volume 
was measured plethys-mometrically, at 1h, 
2h, 3h and 4h respectively.  The percentage 
of inhibition of inflammation was calculated 
for comparison. 
 
The ratio of the anti-inflammatory effect of 
CEEA was calculated by the following 
equation: anti-inflammatory activity(%) = 
(1-D/C)x 100, where D represents  the 
percentage difference in paw volume after 
CEEA was administered to the rats, and C 
represents the percentage difference of 
volume in the control groups. 
 
Mediator induced inflammation 
 
The anti-inflammatory activity of the extract 
was measured with phlogistic agents (viz. 
histamine, 5-HT) which act as mediator of 
inflammation.  The paw oedema was 
induced in rats by sub plantar injection of 
freshly prepared histamine (1mg/kg) and 
serotonin (1mg/kg) solutions respectively   Pages 112 - 118   
and the paw oedema was measured as 
mentioned earlier (8).  Cotton pellets-
induced granuloma 
 
The rats were divided into four groups 
(n=6).  The cotton pellet granuloma model 
investigated the proliferation phase of 
inflammation (9).  The extract of different 
doses (50,100, and 200 mg/kg) and 
Indomethacin at 10 mg/kg body weight was 
given to the animals orally.   After shaving 
the fur, the rats were anaesthetized and 10 
mg of sterile cotton pellets were inserted, 
one in each axilla.  The extracts was 
administered  daily  for a period of seven 
days.  The rats were sacrificed after a high 
dose of anesthesia on the eighth day and the 
pellets were removed surgically and made 
free form extraneous tissues. The pellets 
were incubated at 37o C for 24h and dried at 
60o C to constant weight.  Increment in the 
dry weight of the pellets was taken as 
measure of granuloma formation. 
 
Statistical Analysis 
 
The results are expressed as mean ± SEM.  
The statistical analysis was performed by 
ANOVA test. 
 
Result 
 
Anti-inflammatory studies 
 
The anti-inflammatory potential of CEEA 
(50,100 and 200 mg/kg) against various 
experimental animal models exhibited 
significant (P<0.05) anti-inflammatory 
activity.  The effects of CEEA and 
Indomethacin  on the inflammation induced 
by carrageenin, histamine and cotton pellet 
induced granuloma are summarized in table 
3-5. 
 
As shown in table1, CEEA showed 
maximum inhibition of 55.85% at the dose 
of 200 mg/kg after 3h of treatment in 
carrageenin induced paw oedema,  whereas 
the standard drug (Indomethacin 10 mg/kg)  
Showed 61.30% of inhibition (P<0.05).  The 
CEEA showed 52.55 and 53.55 and 53.51% 
(P<0.001) of inhibition at the dose of 200 
mg/kg whereas indomethacin showed 61.31, 
59.10% of inhibition in histamine and 
serotonin induced paw oedema.  In the 
chronic model (cotton pellet induced 
granuloma), the CEEA (50,100 and 200 
mg/kg) and Indomethacin showed decreased 
formation of granuloma tissue at 46.7, 41.5 
22.1% and 53.48% respectively. 
 
Discussion 
 
The present study establishes the anti-
inflammatory activity of the Eclipta alba 
extract in standard experimental animal 
models.  The effect of CEEA at the dose of 
50,100 and 200 mg/kg showed significant 
anti-inflammatory activity.  It is evident that 
carrageenin is commonly used to induce 
acute inflammation and is believed to be bi-
phasic.  Based on this, it could be argued 
that the suppression of the first phase may 
be due to inhibition of the release of early 
mediators, such as histamine and serotonin, 
and the action in the second phase may be 
explained by an inhibition of cyclo-
oxygenase.  These mediators take part in the 
inflammatory response and are able to 
stimulate nociceptor and thus induce pain 
(10).  It has been reported that second phase 
of oedema  is sensitive to most clinically 
effective anti-inflammatory drugs, which 
has been frequently used to access the anti-
oedematous effect of natural products (10-
11).  Based on these reports, it can be 
inferred that the inhibitory effect of the 
extract of Eclipta alba  on carrageenin-
induced inflammation in rats may by due to 
inhibition of the mediators responsible for 
inflammation. 
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Histamine is the one the important 
inflammation mediators and it is potent 
vasodilators substance and increase the 
vascular permeability (12-13).  The study 
showed that the dose CEEA effectively 
suppressed the odema produced by the 
histamine, which indicates that the extract 
exhibit the anti –  inflammatory action by 
means of either inhibiting the syntheses, 
release or action of inflammatory mediators 
viz.  histamine, serotonin and 
prostaglandin’s might be involved in the 
inflammation.  So, it is suggested that the 
anti-inflammatory activity is possibly 
backed by its anti-histaminic activity. 
 
The extract exhibited significant anti-
inflammatory activity on the cotton pellet 
test.  The cotton pellet granuloma is widely 
used to evaluate the transudative and 
proliferative components of the chronic 
inflammation.  The moist weight of pellets 
correlates with transude, the dry weight of 
the pellet of the correlates with the amount 
of granulomatous tissues (14-15).  Chronic 
inflammation occurs by   means of the 
development of proliferate cells.  These cells 
can either spread or be in granuloma form.  
Non-steroidal anti-inflammatory drugs 
decrease the size of granuloma, which 
results from cellular reaction by inhibiting 
granulocyte infiltration/inflammation, 
preventing generation of collagen fibers and 
suppressing mucopolysaccharides (16 – 17).  
The  Eclipta alba  showed  significant  anti-
inflammatory activity in cotton-pellet 
induced granuloma and thus found to  be 
effective in chronic inflammatory 
conditions, which reflected its efficacy in 
inhibiting the increase in the number of 
fibroblasts and synthesis of collagen and 
mucopolysaccharides during granuloma 
tissue formation. 
 
So, we can conclude that the present study 
show that the chloroform extract of Eclipta 
alba  exhibit significant anti-inflammatory 
activity against early phase (acute paw 
edema), late phase (cotton pellet granuloma) 
of inflammation models without any 
deleterious side effect.  The anti-
inflammatory activity could be attributed to 
the presence of phytopharamacophore and 
also it may be due to the synergistic effects 
of various active compounds in the plant. 
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Table 1. Effect of the Eclipta alba extract on carrageenin  
induced pedal oedema 
 
Treatment                            Dose                        Paw volume                      Percentage of  
                                          (mg/kg)                             (ml)                                 inhibition 
Carrageenin control                 0                          0.734 ± 0.071                                 - 
 
Indomethacin                          10                         0.284 ± 0.016                                61.30 
 
CEEA                                      50                         0.457 ± 0.031                                37.73 
 
CEEA                                      100                       0.396 ± 0.031                                46.04 
 
CEEA                                      200                        0324 ± 0.026                                 55.85     
Values are mean ± SEM (n=6). Experimental groups were compared with control p<0.001.   Pages 112 - 118   
  
Table 2.  
Effect of Eclipta alba extract on mediators like histamine and 5 – HT induced  
pedal oedema in rats 
 
 Treatment                            Dose                       Paw volume                      Percentage of  
                                          (mg/kg)                             (ml)                                 inhibition 
 
Histamine control                     0                          0.548 ± 0057                                    - 
 
Indomethacin                          10                         0.212 ± 0.018                                61.31 
 
CEEA                                      50                         0.348 ± 0.032                                34.67  
 
CEEA                                      100                       0.321 ± 0.022                                41.42 
 
CEEA                                      200                        0.260 ± 0.015                                 52.55     
 
Serotonin control                       0                         0.626 ± 0.054                                     - 
 
Indomethacin                           10                        0.256 ± 0.025                                  59.10 
 
CEEA                                        50                       0.472 ± 0.045                                 24.60 
 
CEEA                                      100                       0.325 ± 0.035                                 43.76  
 
CEEA                                      200                      0.291 ± 0.027                                  53.57 
Values are mean ± SEM (n=6). Experimental groups were compared with control p<0.001. 
 
Table 3. Effect of Eclipta alba extract on Cotton-pellets  
induced granuloma in rats 
 
Treatment                            Dose             Weight of cotton pellet                   Percentage of  
                                          (mg/kg)                             (ml)                                 inhibition 
 
Control                                     0                         445 ± 4.5                                         - 
 
Indomethacin                          10                         268 ± 2.2                                      53.48 
 
CEEA                                      50                        29.3 ± 2.4                                     27.41 
 
CEEA                                      100                      32.1 ± 2.6                                     38.42 
 
CEEA                                      200                       22.3 ± 1.5                                    55.23     
Values are mean ± SEM (n=6). Experimental groups were compared with control p<0.001.   Pages 112 - 118   
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